academic article

• Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort..  JAMA ophthalmology.  :1-10. 2015
• Intensive diabetes therapy and ocular surgery in type 1 diabetes. 2015
• Poor Glycemic Control is Associated with Reduced Prostate Specific Antigen Concentrations in Men with Type 1 Diabetes. 2015
• Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC..  Diabetes.  64:631-642. 2015
• The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes..  Journal of diabetes and its complications.  29:108-114. 2015
• Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality..  JAMA : the journal of the American Medical Association.  313:45-53. 2015
• Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes..  Diabetes.  64:266-278. 2015
• Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study..  Diabetic medicine : a journal of the British Diabetic Association.  31:1264-1268. 2014
• Renal outcomes in patients with type 1 diabetes and macroalbuminuria..  Journal of the American Society of Nephrology : JASN.  25:2342-2350. 2014
• Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC..  The Journal of clinical endocrinology and metabolism.  99:E1655-E1660. 2014
• GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence..  Diabetologia.  57:1623-1634. 2014
• Musculoskeletal complications in type 1 diabetes. 2014
• Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort. 2014
• Self-reported autoimmune disease by sex in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. 2014
• Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions..  Diabetes.  62:3976-3986. 2013
• Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes..  Atherosclerosis.  231:315-322. 2013
• Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy..  Ophthalmology.  120:2580-2586. 2013
• Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC..  Diabetes.  62:3561-3569. 2013
• The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study. 2013
• The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort. 2013
• Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study..  Diabetes.  62:3218-3223. 2013
• Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. 2013
• Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes. 2013
• Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study..  Diabetes technology & therapeutics.  15:466-474. 2013
• Long-term effect of diabetes and its treatment on cognitive function..  The New England journal of medicine.  356:1842-1852. 2007
• Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes..  Diabetes.  63:1748-1762.